Alembic Pharmaceuticals informs about press release

26 Nov 2018 Evaluate

Alembic Pharmaceuticals has informed that the company's joint venture, Aleor Dermaceuticals, has received United States Food and Drugs Administration (USFDA) Approval for Lidocaine Ointment USP, 5%. Further, the company has submitted the press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

673.60 27.35 (4.23%)
24-Mar-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.80
Dr. Reddys Lab 1260.40
Cipla 1219.30
Zydus Lifesciences 887.00
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×